UPDATE: Ladenburg Thalmann Downgrades CNS Pharmasceuticals Inc. (CNSP) to Neutral Dec 28, 2020 07:13AM
CNS Pharmaceuticals to Discuss Phase 2 Clinical Trial Design to be Submitted for FDA Review in Webcast at 4:30 PM ET Today Nov 12, 2020 08:00AM
CNS Pharmaceuticals (CNSP) Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review Nov 9, 2020 08:14AM
CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review Nov 9, 2020 08:00AM